Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details 1)

v3.20.2
Shareholders' Deficit (Details 1)
9 Months Ended
Sep. 30, 2020
$ / shares
shares
Number of Non-vested Shares  
Balance, Beginning | shares 17,675,299
Granted | shares 7,450,000
Shares vested | shares (1,273,373)
Balance, Ending | shares 23,851,926
Weighted Average Grant Date Fair Value  
Balance, Beginning | $ / shares $ 0.23
Granted | $ / shares 0.04
Shares vested | $ / shares (0.41)
Balance, Ending | $ / shares $ 0.16